50 related articles for article (PubMed ID: 8967732)
1. Mitomycin C and lonidamine as second-line treatment of advanced colorectal cancer patients.
Maiello E; Giotta F; Gebbia V; Testa A; Galetta D; Riccardi F; Gebbia N; Colucci G
Anticancer Res; 1996; 16(5B):3177-9. PubMed ID: 8967732
[TBL] [Abstract][Full Text] [Related]
2. [Optimal dosage of UFT + MMC combination chemotherapy for advanced colorectal cancer--phase I/II study of combination chemotherapy of MMC with 2-week intervals and intermittent UFT administration--Study Group of UFTM Therapy for Advanced Colorectal Cancer].
Ikeda E; Kodaira S; Teramoto T; Okuda M; Takahashi T; Kato T; Yamamoto Y; Isomoto H
Gan To Kagaku Ryoho; 1996 Sep; 23(10):1291-8. PubMed ID: 8831741
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
[TBL] [Abstract][Full Text] [Related]
4. UFT/leucovorin and mitomycin C as salvage treatment in patients with advanced colorectal cancer - a retrospective analysis.
Vormittag L; Kornek GV; Gruhsmann B; Lenauer A; Föger A; Depisch D; Lang F; Scheithauer W
Anticancer Drugs; 2007 Jul; 18(6):709-12. PubMed ID: 17762401
[TBL] [Abstract][Full Text] [Related]
5. Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer.
Caponigro F; Avallone A; McLeod H; Cartenì G; De Vita F; Casaretti R; Morsman J; Blackie R; Budillon A; De Lucia L; Gravina A; Catalano G; Comella P; Comella G
Clin Cancer Res; 1999 Dec; 5(12):3948-55. PubMed ID: 10632324
[TBL] [Abstract][Full Text] [Related]
6. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
[TBL] [Abstract][Full Text] [Related]
7. Capecitabine and mitomycin-C in the therapy of pretreated patients with metastatic colorectal cancer: single center retrospective study with 36 patients.
Vrdoljak E; Omrcen T; Boban M; Hrepic D
J BUON; 2008; 13(4):513-8. PubMed ID: 19145672
[TBL] [Abstract][Full Text] [Related]
8. Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide.
Papaldo P; Lopez M; Cortesi E; Cammilluzzi E; Antimi M; Terzoli E; Lepidini G; Vici P; Barone C; Ferretti G; Di Cosimo S; Nistico C; Carlini P; Conti F; Di Lauro L; Botti C; Vitucci C; Fabi A; Giannarelli D; Marolla P
J Clin Oncol; 2003 Sep; 21(18):3462-8. PubMed ID: 12972521
[TBL] [Abstract][Full Text] [Related]
9. Raltitrexed plus oxaliplatin in the second-line treatment of metastatic colorectal cancer.
Vyzula R; Kocáková I; Demlová R; Kiss I; Dusek L; Jarkovský J
Neoplasma; 2006; 53(2):119-27. PubMed ID: 16575467
[TBL] [Abstract][Full Text] [Related]
10. 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer.
Sobrero A; Guglielmi A; Cirillo M; Recaldin E; Frassineti GL; Aschele C; Ravaioli A; Testore P; Caroti C; Gallo L; Pessi MA; Cortesi E; Turci D; Grossi F; Labianca R
Br J Cancer; 2001 Apr; 84(8):1023-8. PubMed ID: 11308248
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer.
Chau I; Webb A; Cunningham D; Hill M; Waters JS; Norman A; Massey A
Br J Cancer; 2001 Nov; 85(9):1258-64. PubMed ID: 11720458
[TBL] [Abstract][Full Text] [Related]
12. Five-day infusion of fluorouracil and vinorelbine for advanced breast cancer patients treated previously with anthracyclines.
Pieńkowski T; Jagiello-Gruszfeld A
Int J Clin Pharmacol Res; 2001; 21(3-4):111-7. PubMed ID: 12067140
[TBL] [Abstract][Full Text] [Related]
13. Mitomycin-C and lonidamine as second-line therapy for colorectal cancer: a phase II study.
Zaniboni A; Meriggi F; Alghisi A; Mutti S; Distefano L; Rizzi A; Bettini L; Simoncini E; Marpicati P; Montini E
Tumori; 1995; 81(6):435-7. PubMed ID: 8804471
[TBL] [Abstract][Full Text] [Related]
14. Revertant and potentiating activity of lonidamine in patients with ovarian cancer previously treated with platinum.
De Lena M; Lorusso V; Bottalico C; Brandi M; De Mitrio A; Catino A; Guida M; Latorre A; Leone B; Vallejo C; Gargano G
J Clin Oncol; 1997 Oct; 15(10):3208-13. PubMed ID: 9336357
[TBL] [Abstract][Full Text] [Related]
15. [Combination chemotherapy of doxifluridine plus mitomycin C for colorectal lung metastasis--phase II study].
Ike H; Sadahiro S; Oya K; Otani Y; Shimada H; Yamaguchi S; Hiki Y; Fujita H; Mitomi T;
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1263-8. PubMed ID: 11579637
[TBL] [Abstract][Full Text] [Related]
16. [Three cases of drug-induced hemolytic uremic syndrome].
Tohda S; Shiigai T; Jibiki M; Aoi T; Ueda Y; Kawasaki T; Kurokawa H; Nara N
Gan To Kagaku Ryoho; 1996 Feb; 23(3):361-4. PubMed ID: 8712831
[TBL] [Abstract][Full Text] [Related]
17. Mitomycin-C, vinblastine, and lonidamine as salvage treatment of advanced breast cancer. A pilot study.
Zaniboni A; Montini E; Simoncini E; Marpicati P; Arcangeli G; Meriggi F; Marini G
Am J Clin Oncol; 1990 Dec; 13(6):520-3. PubMed ID: 2122716
[TBL] [Abstract][Full Text] [Related]
18. Carboplatin and etoposide in previously treated colorectal cancer patients.
Colucci G; Maiello E; Giuliani F; Cifarelli RA; Giotta F
Tumori; 1995; 81(1):36-8. PubMed ID: 7754538
[TBL] [Abstract][Full Text] [Related]
19. Salvage chemotherapy in metastatic colorectal cancer with the combination of capecitabine and mitomycin C.
Zygulska AL; Krzemieniecki K
Neoplasma; 2015; 62(5):793-7. PubMed ID: 26278141
[TBL] [Abstract][Full Text] [Related]
20. Ocular toxicity of systemic chemotherapy with megadoses of carmustine and mitomycin.
Cruciani F; Tamanti N; Abdolrahimzadeh S; Franchi F; Gabrieli CB
Ann Ophthalmol; 1994; 26(3):97-100. PubMed ID: 7944163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
